DEVELOPING: Breakthrough Discovery Reveals Vitamin B3 as Powerful Skin Cancer Protector

BREAKING NEWS Vitamin B3 Supplements Linked to Significant Reduction in Skin Cancer Recurrences, Study Finds A groundbreaking new study published in JAMA Dermatology reveals that taking Vitamin B3 supplements can reduce the risk of non-melanoma skin cancer recurrences by 54% among individuals who have already had skin cancer. The research, which involved nearly 34,000 veterans, found that those who took 500 mg of nicotinamide (also known as niacinamide) twice daily for at least one month after being diagnosed with their first skin cancer saw the greatest reduction in risk. This is a crucial finding for individuals who have already been diagnosed with skin cancer, and highlights the potential benefits of Vitamin B3 supplements in preventing further occurrences. Doctors who perform skin cancer surgeries often recommend nicotinamide to their patients due to its ability to protect cells from UV radiation damage. The study's results are based on data collected over several years, providing a significant body of evidence supporting the use of Vitamin B3 supplements as a preventative measure against non-melanoma skin cancers. As news of this breakthrough spreads, health experts and researchers are urging individuals who have had skin cancer to consult with their doctors about incorporating Vitamin B3 supplements into their treatment plans. This is a developing story. Further updates will be provided as more information becomes available. *This is a developing story. Updates will be provided as more information becomes available. Based on reporting from Npr.*